PATENT CLAIM ANALYSIS

Application Number: 15754934
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "236200"]

Abstract:
The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of inflammatory disease and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

Claim (Index 2):
The compound or salt according to  claim 1 , wherein\n R 1  is a hydrogen atom; R 2  is (1) an optionally substituted C 1-6  alkyl group, (2) an optionally substituted C 3-10  cycloalkyl group, (3) an optionally substituted C 6-14  aryl group, (4) an optionally substituted C 1-16  aralkyl group, (5) an optionally substituted 5- to 14-membered aromatic heterocyclic group, (6) an optionally substituted 3- to 14-membered non-aromatic heterocyclic group, (7) an optionally substituted mono- or di-C 6-14  arylamino group, or (8) an optionally substituted C 1-6  alkoxy group; and R 3  is a hydrogen atom.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.40909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15506380', '15745290', '15210965', '13522070', '14435899']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7825303522423634
- 35 USC 102 Novelty (BERT): 0.5573501249366238
- Combined Prediction Score: 0.7600123295117895
- Mean Citation Score: 361.458788
- Max Citation Score: 406.5847
- Similarity Product: 368.4501052929938

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test